TAM: Transceiver addressable market >$25B by 2028 (Cignal AI); CPO component TAM management raised to >$15B; OCS TAM >$4B.1 OCS pipeline: 10 hyperscaler customers confirmed as of the FQ2 (Dec 2025) earnings call; non-mechanical liquid crystal technology cited by management as a differentiated edge over mechanical switching alternatives.9 Five-year backlog with LTAs extending to 2030+ and customer-funded CapEx embedded in LTAs.
Structural tailwinds: AI cluster interconnect bandwidth doubles with every GPU generation; 800G → 1.6T → 3.2T is a fixed multi-year ramp. Coherent is simultaneously ramping 800G, shipping first 1.6T units, and executing initial CPO scale-out revenue in H2 CY2026.
Moat: 6-inch indium-phosphide fab in Sherman, TX (only commercial 6" InP facility in the US): the transition from 3-inch to 6-inch wafers produces 4× the chip output at half the unit cost — a manufacturing step-change that 3-inch peers cannot match without multi-year retooling.9 Vertical integration (chip → module → system) creates the only one-stop-shop for AI optical infrastructure at scale.
Bear stress-test: CPO becomes the dominant architecture and hyperscalers source lasers directly from chip fabs, bypassing COHR's module business. Not survivable in its current form — but COHR supplies the CW lasers that go into CPO, meaning it benefits from CPO adoption rather than being displaced by it. The real bear case is NVIDIA on-boarding a second InP supplier at scale, which requires 2–4 years of qualification at minimum.
EPS trend (non-GAAP): $0.91 → $1.00 → $1.16 → $1.29 → $1.41 over five sequential quarters. Q4 guide midpoint $1.62 (+14.9% QoQ).1 Estimate revisions: UP — avg target raised +70.68% in past 3 months per ChartMill.5
FCF caveat: Nine-month FY26 operating cash flow only $10.1M (vs $503.3M prior year). Q3 CapEx $290M (up from $112M a year ago) as Coherent doubles 6-inch InP capacity one quarter ahead of plan. FCF is deliberately negative and customer-funded LTAs justify the build — but this is not a self-funding compounder yet.3
Balance sheet: Net leverage cut to 0.5× EBITDA from 2.1× in Q3 FY25; $1.59B cash + $825M short-term investments; $3.18B long-term debt. The $2.00B NVIDIA infusion funded most of the capacity build.1
Form 4 insider activity (90 days to May 2026):
· CFO Sherri Luther: 2,000 shares sold ~$351 (~24 Apr), Rule 10b5-1 plan. Routine.
· Director Howard Xia: 4,240 shares sold $236–$258 (16 Mar-17) via option exercise + same-day sale. Routine.
No discretionary open-market buying; insider ownership only 0.71% of shares. Neutral — not a red flag, but no smart-money reinforcement either.6
Institutional: 80.46% institutional ownership; Ken Fisher expanding stake; Artisan Mid Cap trimmed in Q1 2026 on valuation (did not exit). Short interest: 3.34% of shares out — not elevated.2,7
Customer concentration risk rising: NVIDIA will likely become a >10% customer in FY27 post supply agreement; not yet disclosed separately. Flag for FY26 10-K.
PEG: ~1.2 on consensus forward EPS. Not cheap, not egregious. AI infrastructure peers like ALAB trade at PEG ~2.3+; Inflexion rates DDOG at PEG ~3.4. On relative terms COHR is acceptably priced for the thesis quality.
Distance from entry zone: Spot ~$350 is ~6–20% above the $290–$330 add zone and ~27–36% above the ideal $240–$275 zone. Post-Q3 print the stock corrected 6–7%; further consolidation before the Q4 August print is likely.
Consensus price target vs spot: 1-year consensus PT $311–$315 = ~11–14% below current price. Multiple analysts raised targets post-Q3 (Jefferies $350→$375, TD Cowen $340→$395) but the average is still below spot. Analyst targets are catching up to a stock that has run 400%+ in twelve months.5
My variant vs consensus on EPS path: Consensus FY27 EPS of ~$7–8. My view: if the 6" InP capacity doubling hits on schedule (Q1 CY27) and 1.6T volume ramp delivers the guided margin expansion to 42–43% non-GAAP GM, FY27 non-GAAP EPS could reach $8.50–$9.50 — 15–20% above consensus. This makes the current ~45× forward look closer to ~38–40× on my numbers. Not cheap, but defensible.
Institutional positioning note: Artisan trimmed on valuation. Q2 13F (due 14 Aug) is the next institutional flow signal.
- 01Non-GAAP gross margin contracts sequentially for two consecutive quarters (below 38.5%) by Q2 FY27 — would indicate 6-inch InP yield ramp is failing or customer pricing is deteriorating.
- 02NVIDIA or a top-3 hyperscaler defers or cancels a multi-year LTA, OR NVIDIA on-boards a second qualified InP supplier at scale by end of CY2026 — would fracture the supply exclusivity that underlies the current valuation premium.
- 03Datacenter & Communications segment revenue growth decelerates below +20% YoY for two consecutive quarters by Q4 FY27 — would signal pluggable transceiver pricing collapse or CPO adoption pulling forward faster than COHR can re-mix toward CPO components.
- 01FCF is deeply negative: Nine-month FY26 operating cash flow $10.1M vs $503.3M prior year; Q3 CapEx $290M. If the 6-inch InP yield ramp disappoints, the company is spending $1B+/year with nothing to show for gross margin expansion — risk of a 20–25% de-rate on execution miss.
- 02NVIDIA concentration becoming structural: Post supply agreement, NVIDIA will likely be >10% of revenue in FY27. A single customer accounting for 10–20% of revenue with a $2B equity stake creates both a dependency and a M&A optionality dynamic — the latter is a potential upside (NVDA acquires COHR), the former is downside if NVIDIA's capex decelerates.
- 03CPO disruption timing risk: If hyperscalers accelerate CPO adoption faster than expected (e.g., NVIDIA Spectrum-X 3.0 ships with embedded CPO in 2026 instead of 2027), pluggable transceiver ASPs could compress 15–25% in CY2027, hitting gross margins before COHR's CPO revenue is large enough to offset.
- 04Consensus PT below spot: 12-month consensus PT $311–$315 is ~11–14% below current ~$350 price. Even bulls (TD Cowen $395) project only ~13% upside from here. If the stock does not re-rate on FY27 guidance, the multiple compression path implies a return toward $290–$315 — making current entry unattractive unless you can scale in on weakness.
- 05Geopolitical / export control tail: Sherman, TX fab is domestic (no Taiwan risk) but ~30–40% of revenue is from non-US hyperscaler deployments. Any BIS expansion of export controls on advanced optical components into China or restricted geographies could impact the communications segment ($60M+ quarterly).
Discount rate: 13% — High-growth recently profitable tech (non-GAAP profitable; GAAP improving; FCF currently negative due to planned CapEx surge; consistent with the DCF guide for this risk profile).
FCF base: FY26 ~$0 (CapEx-constrained); FY27 FCF recovers to ~$400–500M as 6-inch InP capacity doubly delivers operating leverage and customer-funded CapEx moderates to <$200M/yr. FY28–FY30 FCF CAGR 40%+ as 1.6T/CPO mix drives non-GAAP GM to 44%+. Revenue: $7.2B FY26 → $9.2B FY27 → $11.8B FY28 → $15.0B FY29 → $19.2B FY30. Requires: 6" InP yield on schedule, 1.6T volumes as guided, CPO revenue inflection H2 CY2026, NVIDIA relationship intact. This is the base case if management executes, not an optimistic outlier.
Pluggable transceiver ASP compression of 20%+ in CY2027 from CPO acceleration or a second qualified InP competitor; D&C growth decelerates to +15% YoY from FY27; gross margin stalls at 39–40% as pricing offsets yield gains; FCF does not recover until FY29. Revenue: $7.2B FY26 → $8.2B FY27 → $9.4B FY28 → $10.7B FY29 → $12.2B FY30. Fair value ~$195 = back to pre-NVIDIA-deal multiple on flat-to-slow growth.
-
2026-066-inch InP capacity doubling milestone — Coherent guided to complete one quarter ahead of schedule (by end CY2026). Any press release or analyst-day confirmation of this milestone would validate the gross margin expansion thesis and likely trigger a re-rate toward analyst high targets ($395+).
-
2026-07NVIDIA GTC / partner announcements — Any disclosure of initial CPO scale-out revenue from NVIDIA Spectrum-X or Quantum CPO programmes would be the first quantified proof that the CPO TAM expansion is generating real dollars, not just backlog.
-
2026-08Q4 FY2026 earnings (~12 Aug–14) — The pivotal print. Confirm: (1) Q4 revenue ≥$1.98B midpoint; (2) non-GAAP GM ≥40%; (3) FY27 growth guide >25% YoY. All three together = full-weight add to 5%. A miss on any two = hold at starter.
-
2026-Q41.6T volume ramp at multiple hyperscaler sites — Management guided "broad customer adoption of 1.6T" through H2 CY2026. First disclosure of 1.6T as a material revenue line (>10% of DC&C segment) would confirm the next speed tier is not COHR-specific and marks the beginning of the next ASP-expansion cycle.
1 SEC EDGAR — Coherent Corp. 8-K / Press Release Q3 FY2026, filed 2026-05-06 (EX-99.1); Q3 FY26 earnings call transcript via Motley Fool, 2026-05-06
2 Stockanalysis.com (stockanalysis.com/stocks/cohr/) — forward P/E, PEG, 52W range, institutional %, market cap — accessed 2026-05-12
3 SEC EDGAR — Coherent Corp. Form 10-Q (nine-month cash flow statement) / 8-K supplemental slides — CapEx and OCF figures
4 Investing.com earnings call transcript, 2026-05-06; GlobeNewswire press release, 2026-05-06 — NVIDIA partnership and CPO supply agreement details
5 ChartMill (chartmill.com/stock/quote/COHR/analyst-ratings) — analyst price targets and revision statistics — accessed 2026-05-12 ⚠ single source
6 Stocktitan.net — Form 4 insider filings for COHR CFO and director, Apr–May 2026
7 Yahoo Finance (finance.yahoo.com/quote/COHR) — price, short interest — accessed 2026-05-12; Insider Monkey — Artisan Mid Cap Fund Q1 2026 trim disclosure
8 FinanceCharts — 3-year and 5-year historical P/E averages for COHR ⚠ single source
9 Beth Kindig / IO Fund — The IO Fund's Top 15 Stocks for Q2 2026, "Coherent: Slow and Steady" section; FQ2 earnings analysis covering Dec 2025 quarter. Paywalled (io-fund.com/premium). Used for analyst attribution only; financial metrics on this page sourced from SEC filings and open-access sources above.
⚠ = figure not cross-verifiable from multiple open-access sources. · Q3 FY26 beat/miss: conflicting reads between Investing.com (+1.5% beat) and Quiver Quantitative (–$9.8M miss) — see conflict flag above.